# Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines

**Authors:** Antonio Lopalco, Nunzio Denora

PMC · DOI: 10.3390/pharmaceutics18020209 · 2026-02-06

## Full-text entities

- **Diseases:** dysphagia (MESH:D003680), injury to (MESH:D014947), dystonia (MESH:D004421)
- **Chemicals:** propranolol (MESH:D011433), gallium-68 (MESH:C000615430), trihexyphenidyl (MESH:D014282), sugar (MESH:D000073893), alpha-lipoic acid (MESH:D008063), metronidazole (MESH:D008795)
- **Species:** Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12943938